Cape Town [South Africa]/ Mumbai (Maharashtra) [India], February 4 (ANI/BusinessWire India): Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the Merck Foundation Africa Research Summit - MARS 2022 Awards Ceremony, in partnership with the African Union (Scientific Tec
Thanks to nanoscale drills activated by visible light, the stubborn athlete's foot infection that an estimated 70% of people experience at some point in their lives may become much easier to treat.
New Delhi [India], February 3 (ANI/ATK): A trip to Italy's third-largest city is worthwhile for the pizza alone, but it offers much more. Called by many as Italy's soul, Naples is a hub for experiencing rich history, architecture, and cuisine. From intimate alleyways to the peak of the infam
The tuberculosis vaccine (also known as the BCG vaccine) does not protect the elderly with co-morbidities against illness symptoms induced by a coronavirus infection
The researchers say all major adverse pregnancy outcomes should be recognised as lifelong risk factors for ischemic heart disease and women should be offered appropriate care to help prevent its development.
A new study by researchers at the University of California, Davis, allays those concerns, finding that 6- to 9-month-old babies can form memories of masked faces and recognize those faces when unmasked.
New Delhi [India], February 1 (ANI/PNN): It's no surprise that the recent rise of artificial intelligence has taken the design world by storm. After all, this technology presents incredible opportunities like never before. Anything you imagine will be easily turned into a reality in just a f
When HIV patients get antiviral medication (ART), their viral levels are reduced to the point that a conventional blood test cannot detect the virus. However, once ART is discontinued, detectable HIV resurfaces, infecting new cells. The cells that release the virus to re-ignite the infection
A new vaccine from the University of Georgia could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases.
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID),
New Delhi [India], January 30 (ANI/NewsVoir): On the occasion of Infusion Nurses Day, BD (Becton, Dickinson, and Company) in partnership with the Infusion Nurses Society (INS) India-US Affiliate organized a series of webinars for Infusion nurses and Infection control nurses across Delhi, Che